Payer and Specialty Pharmacy Forum: Improving the Adoption of Oncology Biosimilars in Practice

https://www.pharmacytimes.org/on-demand/ajmc-payer-and-specialty-pharmacy-forum-improving-the-adoption-of-oncology-biosimilars-in-practice

Related Videos

Related Content

Advertisement

May 16th 2025

Review Identifies Top Prognostic Factors in Third-Line or Later DLBCL

AJMC Contributor

A systematic review and subsequent expert review gave comprehensive insight into prognostic factors for patients receiving treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

May 13th 2025

Inside the Center's MDD Value Model and Its Use of Dynamic Pricing

Brooke McCormick Larragem Raines, MS

Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.

May 16th 2025

5 Ways the US Obesity Landscape Strays From the Global Picture

Hayden E. Klein

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial saturation, access, and long-term care distinct from other parts of the world.

May 9th 2025

Frameworks for Advancing Health Equity: Food as Medicine

Giuliana Grossi Colleen Ereditario, MPH, RD, LDN

Learn about how Allegheny Health Network's "Food as Medicine" initiative tackles food insecurity and enhances health through personalized nutrition support.

May 16th 2025

Diabetes Health Gains Outpace Economic Progress, Study Finds

Pearl Steinzor

Despite advances in diabetes care, new research reveals persistent economic disadvantages for middle-aged adults living with the condition.

May 16th 2025

ChatGPT Effectively Answers Patient Questions on CRC Screening

Pearl Steinzor

Study findings show ChatGPT-4o provides accurate, complete, and trustworthy responses to patient-generated colorectal cancer (CRC) screening questions.

Related Content

Advertisement

May 16th 2025

Review Identifies Top Prognostic Factors in Third-Line or Later DLBCL

AJMC Contributor

A systematic review and subsequent expert review gave comprehensive insight into prognostic factors for patients receiving treatment for relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

May 13th 2025

Inside the Center's MDD Value Model and Its Use of Dynamic Pricing

Brooke McCormick Larragem Raines, MS

Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.

May 16th 2025

5 Ways the US Obesity Landscape Strays From the Global Picture

Hayden E. Klein

While the US leads in early-phase obesity trials and investment, the country also faces challenges in disease burden, trial saturation, access, and long-term care distinct from other parts of the world.

May 9th 2025

Frameworks for Advancing Health Equity: Food as Medicine

Giuliana Grossi Colleen Ereditario, MPH, RD, LDN

Learn about how Allegheny Health Network's "Food as Medicine" initiative tackles food insecurity and enhances health through personalized nutrition support.

May 16th 2025

Diabetes Health Gains Outpace Economic Progress, Study Finds

Pearl Steinzor

Despite advances in diabetes care, new research reveals persistent economic disadvantages for middle-aged adults living with the condition.

May 16th 2025

ChatGPT Effectively Answers Patient Questions on CRC Screening

Pearl Steinzor

Study findings show ChatGPT-4o provides accurate, complete, and trustworthy responses to patient-generated colorectal cancer (CRC) screening questions.